VeriMomaesculus hippocastanum fruit powder é seguro durante a gravidez?
No EU Annex II (ban) or Annex III (restriction) listing or harmonised CLP reproductive classification was identified for Aesculus hippocastanum (CAS 8053‑39‑2). Authoritative reviews (EMA assessment, NCCIH) state safety in pregnancy/lactation is not established and recommend avoidance for lack of data rather than reporting proven reproductive toxicity; peer‑reviewed reviews of topical cosmetic uses report limited adverse effects (contact dermatitis) but not developmental/reproductive hazards. Thus there is no direct evidence of reproductive hazard, but exposure from topical use is considered low but measurable. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
Related ingredients
Frequently asked questions
- aesculus hippocastanum fruit powder é seguro durante a gravidez?
- No EU Annex II (ban) or Annex III (restriction) listing or harmonised CLP reproductive classification was identified for Aesculus hippocastanum (CAS 8053‑39‑2). Authoritative reviews (EMA assessment, NCCIH) state safety in pregnancy/lactation is not established and recommend avoidance for lack of data rather than reporting proven reproductive toxicity; peer‑reviewed reviews of topical cosmetic uses report limited adverse effects (contact dermatitis) but not developmental/reproductive hazards. Thus there is no direct evidence of reproductive hazard, but exposure from topical use is considered low but measurable. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
- aesculus hippocastanum fruit powder é seguro durante a amamentação?
- Same rationale as pregnancy: no harmonised reproductive/CMR classification or EU ban/restriction found; EMA/NCCIH note insufficient data and advise caution. Maternal topical exposure could lead to low but measurable systemic exposure; no infant‑specific toxicity data were found. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
- aesculus hippocastanum fruit powder é seguro para a pele do bebê?
- No evidence of intrinsic reproductive or developmental toxicity to infants from topical exposure to cosmetic‑grade horse‑chestnut extract. Because baby skin (0–3 yr) has higher permeability and surface‑area‑to‑weight, exposure score is increased by +1 relative to adults (topical adult e=1 → baby e=2). Reports flag contact dermatitis cases but not systemic developmental effects. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18503457/?utm_source=openai))
- Como o VeriMom pontua aesculus hippocastanum fruit powder?
- O VeriMom pontua aesculus hippocastanum fruit powder em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a aesculus hippocastanum fruit powder na gravidez?
- Veja nossa lista curada de alternativas seguras a aesculus hippocastanum fruit powder com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.